Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
trading so weird & slow, added only because my buddy georgie18 says 15.80 was a buy
Filled Buy 96 CHFS Limit 13.20 -- -- 15:44:32 11/15/17
Filled Buy 100 CHFS Limit 13.20 -- -- 15:44:35 11/15/17
Filled Buy 4 CHFS Limit 13.20 -- -- 15:44:35 11/15/17
Filled Buy 100 CHFS Limit 13.87 -- -- 15:23:50 11/15/17
Filled Buy 100 CHFS Limit 13.87 -- -- 15:23:50 11/15/17
Yep here is my sell order! It is crazy when people question honest people! If anyone has E Trade they can go into their transactions and see how they list them! I copied the line of the sell but I also had a second sell lower in my other E Trade account! I sold twice today the lower one is the last sell order! Now you kids go play it is over here now!
11/15/17 Sold -1100 of CHFS @ $20.27 22,291.40
Here is the other one from earlier in the day. I sold this one a bit premature during the run but I always take profits on insane runners. I only had a small amount in this second E Trade account compared to my other account as anyone can clearly see.
11/15/17 Sold -638 of CHFS @ $18.60 11,861.49
prob why your NotRichYet2
Flipping these big runners is lucrative, there you go...some advice, free.
That's DEFINITELY not an ANSWER
your probably missing profits from flipping it? I'm not.....
CHFS went up today on absolutely NO NEWS whatsoever ? LOL
Only 537k in the float as there was a 30 for 1 R/S in JAN 2017 AND AND a 29 for 1 R/S in OCT 2017 because of drop due to large loses.
VOLUME not making any sense to me
WHAT AM I MISSING ??? TIA
If it loses 50% of gains by close, odds are it won't follow thru
OF COURSE YOU DID!LMFAO!!!!!!!!!
my cash register has closed for the day, in/out....yea baby...this and Led S wow....
BACK OVER $20'S unreal WHATTA {{{BEAST}}}
Jumped in at $8.00 out at $15.00, back in at $12.50 and out at $20.35, wish my A. L. R. T position that only cost me $0.03 a penny stock and also a medical device maker would have a run like this trade did today.
Out at $20.27. Have a great day everyone. Today was fun. I never sold on the bigger run to $24 and never panic sold on the shakeout and halt. Looked to sell over $20.00 and did.
Wow, what's going on here today! CHFS
http://www.zerohedge.com/news/2017-11-15/forget-bitcoin-nanocap-stock-500-today
looks like it might test 15.00 support ish....on the 5 minute chart
yeah UPdump to $21
Made up the money I lost and then some with that pop got out at .21
woops...halted/bad halt most likely...thus, ya got to take most all profits on the spikes w these crazy runners, as most all of us know...
I was from $5.7 to $21... GLTA
dip to $20 would be nice...lol
Fellas what a big payday for the Holidays. Christmas has been coming very early this year. CHFS is the star on the tree this year.
Oh boy - this crash will be painful
MEGA UPSIDE !!!!!
Still holding strong. my biggest payday this year since DCIX.
Wish I could say I held mann.. I def sold wayyyyy to early.. smh
lol When I hold stocks this long it normally does the reverse lol..
Epic stuff goin on right now... Ppl should be watch out for 25-30 area.. SEC might hate.. If not after hours through tomorrow morning will be superrrrr
in/out, waiting for another scalp......+7500 who alerted this yesterday, I need to meet that person!!! and follow.....
even though 3.00 - 220.60 is CHFS 52w range
thats a silly statement
Wow, got in late @ 16.00, sweet scalp @ 21.00
20,000 share block @ $20 gobbled up in second$$$
CHFS
I was wondering where you were.
Oh man...I would go back out and have another lunch...with cocktails!! lol
Talk about bad timing for a morning meeting. This beast was already up 200% 'at first glance'. Argh!!
At current price $17 per share, Market Cap is still only $10,642,000...based upon meta data released this should double from here!
BOOM SHAKA LACKA....$30+ THIS WEEK...CHFS
from your 4.80 still nice trade
CONGRAT$ to all who are making money with CHFS
im sure yesterdays holders are happy
imagine coming home for Lunch and checking your 10k shares of CHFS
NEWS: > CHF Solutions, Inc. Announces Ultrafiltration Meta-Analysis Highlighting Significant Reduction in Heart Failure Readmissions at 90 Days
8 days 3 hours 49 minutes ago - DJNF
CHF Solutions, Inc. Announces Ultrafiltration Meta-Analysis Highlighting Significant Reduction in Heart Failure Readmissions at 90 Days
EDEN PRAIRIE, Minn., Nov. 07, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today that the Heart Failure Reviews released a comprehensive meta-analysis(1) evaluating the role of ultrafiltration (UF) in reducing hospital readmissions in acute decompensated heart failure (ADHF) patients. The positive results of this meta-analysis, which included CHF Solutions' Aquadex FlewFlow(R) system, are consistent with previous publications that demonstrate the importance of considering Aquapheresis as an alternative therapy for diuretic-resistant, ADHF patients suffering from fluid overload.
Nine (9) studies with a total of 820 patients were included in the analysis. The analysis showed:
-- Reduction in cumulative heart failure hospital readmissions in UF
patients
-- Significant reduction in heart failure readmissions at 90 days for
patients treated with UF (p = 0.01)
-- Significantly higher fluid removal (p < 0.0001)="" and="" weight="" loss="" in="" uf="">
patients (p < 0.00001)="">
-- No differences in renal and cardiovascular outcomes
The data suggests the advantage of UF over conventional diuretics lies in the fluid removal, sodium clearance and prevention of the neural hormonal activation. Recent evidence also suggests that rapid removal of isotonic fluid with ultrafiltration has a high correlation to the reduction in congestive symptoms, sustained heart failure stabilization, reduced diuretic requirements and reduced hospital admissions. The study concluded that UF has the potential to provide extended symptom-free days which may reduce overall health care cost.
John Erb, CHF Solutions CEO said, "We are pleased to see yet another independent piece of clinical evidence validating our mission to provide an alternative therapy for congestive heart failure patients. We remain focused on the clinical and economic benefits that Aquapheresis can provide to patients and hospitals."
About CHF Solutions
CHF Solutions, Inc. (NASDAQ:CHFS) is a medical device company focused on commercializing the Aquadex FlexFlow system for Aquapheresis(R) therapy. The Aquadex FlexFlow system, is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. All treatments must be administered by a healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies. The company's objective is to improve the quality of life for patients with heart failure and related conditions. CHF Solutions is a Delaware corporation headquartered in Minneapolis, Minnesota with wholly owned subsidiaries in Australia and Ireland. The company has been listed on the NASDAQ Capital Market since February 2012.
(1) Siddiqui WJ, Kohut AR, Hasni SF, Goldman JM, Silverman B, Kelepouris E, Eisen HJ, Aggarwal S; Readmission rate after ultrafiltration in acute decompensated heart failure: A systematic review and meta-analysis. Heart Fail Rev. 2017 Sep 13. doi 10.1007/s10741-017-9650-3.
For further information, please contact:
Claudia Napal Drayton Investor Relations
Chief Financial Officer CHF Solutions, Inc.
CHF Solutions, Inc. ir@chf-solutions.com
T: +1-952-345-4205
-or-
Bret Shapiro
Managing Partner
CORE IR
516 222 2560
brets@coreir.com
www.coreir.com
(END) Dow Jones Newswires
November 07, 2017 08:00 ET (13:00 GMT)
Followers
|
65
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1655
|
Created
|
07/06/12
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |